Research study Program year 2021 Source: CMS Open Payments

Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Also Using Insulin Glargine, With a 6-month Safety Extension Period

ClinicalTrials.gov NCT03211858

Research payments

$429,981

98 payments

Through program year 2021, $429,981 in research payments was reported against Six-month, Randomized, Open-label, Parallel-group Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Also Using Insulin Glargine, With a 6-month Safety Extension Period, across 98 payments, paid by Sanofi US Services Inc..

Paid by: Sanofi US Services Inc.
ClinicalTrials.gov: NCT03211858

By program year

3 rows

Year	Kind	Amount	Payments
2021	Research	$3,500	1
2020	Research	$53,225	8
2019	Research	$373,257	89

Breakdown

Who paid Research payments · program years 2019–2021

Sanofi US Services Inc. $429,981 98 payments

Who received the money Research payments · program years 2019–2021

Medical Investigations INC Organisation paid for research $32,323 6 payments
Mercy Clinics, Inc. Organisation paid for research $30,004 7 payments
Elite Research Center LLC Organisation paid for research $27,903 7 payments
Optimum Clinical Research INC Organisation paid for research $24,808 5 payments
Western University Of Health Sciences Organisation paid for research $21,320 2 payments
Baylor Research Inst Bri Organisation paid for research $19,419 3 payments
Endocrine Associates Of West Village, PC Organisation paid for research $17,550 1 payment
Endocrine Associates Of West Village,PC Organisation paid for research $17,170 3 payments
Helena W Rodbard MD Michael Dempsey MD Organisation paid for research $16,000 3 payments
Massresearch, LLC Organisation paid for research $15,953 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.